Radioisotopes, or radionuclides, are particles that emit energy. Some of these particles (alpha and beta particles) emit damaging radiation that can be attached to carrier molecules to directly target cancer cells within the bloodstream. We at Weill Cornell Medicine and NewYork-Presbyterian are proud to offer clinical trials utilizing both types of radioisotopes.
Find out more about how our team uses radionuclide therapy to treat genitourinary cancers.
What's New in GU? 